A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients.

Clin Transl Med · 2024 · PMC10958125 · PMID 38515274

Europe PMC DOI

hedged sentence

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

of borderline significancep = .065so close (0.05 < p ≤ 0.1)

At day 15, the reduction was of borderline significance ( p = .065), while at day 57, the level was significantly reduced compared with day 0 ( p = .031).

also in 421 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.